These include: Heart-related conditions: Conditions such as high blood pressure (hypertension), coronary artery disease, heart valve disease, heart failure, and previous heart attacks can lead to tachycardia
The lawsuits accuse the manufacturers of inadequate warning, failure to warn, and breach of warranty
Receptor Targets: The Fundamental Difference The simplest way to orient the comparison is by receptor target profile: Semaglutide: GLP-1 receptor agonist only Tirzepatide: Dual GIP receptor + GLP-1 receptor agonist Retatrutide: Triple GLP-1 receptor + GIP receptor + Glucagon receptor agonist Each added receptor target brings a distinct mechanism and research dimension
debut in Austin, Texasand I will be there
Jordan Miller, then an undergraduate student at UT San Antonio, wanted to find out whether the surge in poison control cases was directly connected to the FDA's expanded approval of semaglutide or if the timing was merely coincidental